20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Tetrazepam, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2008-288 - Rev 01
This Chemical Type CEP, issued on July 27, 2010, remains in force until June 15, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 1738 associated with this CEP further emphasizes